Lupin’s subsidiary — Novel Laboratories’ Somerset facility is recalling 46,700 bottles of Morphine Sulfate extended-release tablets, used to treat severe pain, in the US market. The recalling is in various strengths due to failed impurities/degradation specifications.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.
The post Lupin’s arm recalls Morphine Sulfate extended-release tablets in US appeared first on Udaipur News | Udaipur Latest News | udaipur local news.
